2022年度论文（SCI收录）
1. Mo Y, Wang Y, Wang Y, Deng X, Yan Q, Fan C, Zhang S, Zhang S, Gong Z, Shi L, Liao Q, Guo C, Li Y, Li G, Zeng Z, Jiang W, Xiong W, Xiang B*. Circular RNA circPVT1 promotes nasopharyngeal carcinoma metastasis via the β-TrCP/c-Myc/SRSF1 positive feedback loop. Mol Cancer. 2022 Oct 5;21(1):192. (IF: 41.44)（向波组）
2. Wang Y, Yan Q, Mo Y, Liu Y, Wang Y, Zhang S, Guo C, Wang F, Li G, Zeng Z, Xiong W*. Splicing factor derived circular RNA circCAMSAP1 accelerates nasopharyngeal carcinoma tumorigenesis via a SERPINH1/c-Myc positive feedback loop. Mol Cancer. 2022 Feb 28; 21(1): 62. (IF: 41.44)（熊炜组）
3. Jiliang Xia, Jingyu Zhang, Xuan Wu, Wanqing Du, Yinghong Zhu, Xing Liu, Zhenhao Liu, Bin Meng, Jiaojiao Guo, Qin Yang, Yihui Wang, Qinglin Wang, Xiangling Feng, Guoxiang Xie, Yi Shen, Yanjuan He, Juanjuan Xiang, Minghua Wu, Gang An, Lugui Qiu, Wei Jia, Wen Zhou. Blocking glycine utilization inhibits multiple myeloma progression by disrupting glutathione balance. Nature Communications. 13(1):4007. (IF: 17.694)（周文组）
4. Xiangling Feng, Jiaojiao Guo, Gang An, Yangbowen Wu, Zhenhao Liu, Bin Meng, Nihan He, Xinying Zhao, Shilian Chen, Yinghong Zhu, Jiliang Xia, Xin Li, Zhiyong Yu, Ruixuan Li, Guofeng Ren, Jihua Chen, Minghua Wu, Yanjuan He, Lugui Qiu, Jiaxi Zhou, Wen Zhou. Genetic Aberrations and Interaction of NEK2 and TP53 Accelerate Aggressiveness of Multiple Myeloma. Advanced Science. 9(9):e2104491. (IF: 17.521)（周文组）
5. Chengde Gao, Zihao Zeng, Shuping Peng, Cijun Shuai. Magnetostrictive alloys: Promising materials for biomedical applications. Bioactive Materials. 8: 177–195. (IF: 17.363)（彭淑平组）
6. Wang J, Ge J, Wang Y, Xiong F, Guo J, Jiang X, Zhang L, Deng X, Gong Z, Zhang S, Yan Q, He Y, Li X, Shi L, Guo C, Wang F, Li Z, Zhou M, Xiang B, Li Y, Xiong W*, Zeng Z*. EBV miRNAs BART11 and BART17 - 3p promote immune escape through the enhancer - mediated transcription of PD - L1. Nat Commun. 2022 Feb 14; 13(1): 866. (IF: 14.919)（曾朝阳/熊炜组）
7. Fangwei Qi, Ruobing Liao, Yang Shuai, Hao Pan, Guowen Qian, Shuping Peng, Cijun Shuai. A conductive network enhances nerve cell response. ADDITIVE MANUFACTURING. 52. (IF: 13.695)（彭淑平组）
8. Peng Q, Zhou Y, Oyang L, Wu N, Tang Y, Su M, Luo X, Wang Y, Sheng X, Ma J*, Liao Q*. Impacts and mechanisms of alternative mRNA splicing in cancer metabolism, immune response, and therapeutics. Molecular Therapy. 2022 Mar 2;30(3):1018 - 1035. (IF: 11.49)（马健组）
9. Chen J, Zhu H, Yin Y, Jia S, Luo X. Colorectal cancer: Metabolic interactions reshape the tumor microenvironment. Biochim Biophys Acta Rev Cancer. 1877 (5):188797. (IF: 11.4)（罗湘建组）
10. Wang Y, Mo Y, Peng M, Zhang S, Gong Z, Yan Q, Tang Y, He Y, Liao Q, Li X, Wu X, Xiang B, Zhou M, Li Y, Li G, Li X, Zeng Z, Guo C*, Xiong W*. The influence of circular RNAs on autophagy and disease progression. Autophagy. 2022 Feb; 18(2): 240 - 253. (IF: 11.059)（熊炜组）
11. Liu N, Shi F, Yang L, Liao W, Cao Y. Oncogenic viral infection and amino acid metabolism in cancer progression: Molecular insights and clinical implications. Biochim Biophys Acta Rev Cancer. 1877（3）：188724. (IF: 10.769)（石峰/曹亚组）
12. Quan J, Cheng C, Tan Y, Jiang N, Liao C, Liao W, Cao Y, Luo X. Acyl-CoA synthetase long -chain 3-mediated fatty acid oxidation is required for TGFβ1-induced epithelialmesenchymal transition and metastasis of colorectal carcinoma. Int J Biol Sci. 18(6):2484 - 2496. (IF: 10.75)（罗湘建组）
13. Mingli Yang, Yang Shuai, Youwen Yang, Da Zeng, Shuping Peng, Zongjun Tian, Cijun Shuai. In situ grown rare earth lanthanum on carbon nanofiber for interfacial reinforcement in Zn implants. Virtual and Physical Prototyping. 17:3, 700 - 717. (IF: 10.711)（彭淑平组）
14. Youwen Yang, Jun Zan, Yang Shuai, Liuyimei Yang, Lemin Zhang, Hanqing Zhang, Dongsheng Wang, Shuping Peng, Cijun Shuai. In Situ Growth of a Metal-Organic Framework on Graphene Oxide for the Chemo-Photothermal Therapy of Bacterial Infection in Bone Repair. ACS APPLIED MATERIALS & INTERFACES. 14, 21996−22005. (IF: 10.382)（彭淑平组）
15. Fangwei Qi, Xiuwen Gao, Yang Shuai, Shuping Peng, Youwen Deng, Sheng Yang, Youwen Yang, Cijun Shuai. Magnetic-driven wireless electrical stimulation in a scaffold. COMPOSITES PART B - ENGINEERING. 237. (IF: 10.133)（彭淑平组）
16. Jiang X, Deng X, Wang J, Mo Y, Shi L, Wei F, Zhang S, Gong Z, He Y, Xiong F, Wang Y, Guo C, Xiang B, Zhou M, Liao Q, Li X, Li Y, Li G, Xiong W, Zeng Z*. BPIFB1 inhibits vasculogenic mimicry via downregulation of GLUT1-mediated H3K27 acetylation in nasopharyngeal carcinoma. Oncogene. 2022 Jan;41(2):233-245. (IF: 9.786)（曾朝阳组）
17. Tang M, Dong X, Xiao L, Tan Z, Luo X, Yang L, Li W, Shi F, Li Y, Zhao L, Liu N, Du Q, Xie L, Hu J, Weng X, Fan J, Zhou J, Gao Q, Wu W, Zhang X, Liao W, Bode A M, Cao Y. CPT1A - mediated fatty acid oxidation promotes cell proliferation via nucleoside metabolism in nasopharyngeal carcinoma. Cell Death Dis. 13（4）：331. (IF: 9.62)（曹亚组）
18. Wei Xu, Linna Chen, Jiheng Liu, Zhezhe Zhang, Ranran Wang, Qianqian Zhang, Huiting Li, Juanjuan Xiang, Li Fang, Ping Xu and Zheng Li. LINC00152 induced by TGF - β promotes metastasis via HuR in lung adenocarcinoma. Cell Death Dis. 2022, 13:772 - 785. (IF: 9.62)（李征组）
19. Lujuan Wang, Qiu Peng, Yaohuan Xie, Na Yin, Jiaqi Xu, Anqi Chen, Junqi Yi, Wenhua Shi, Jingqun Tang, Juanjuan Xiang. Cell - cell contact - driven EphB1 cis - and trans - signalings regulate cancer stem cells enrichment after chemotherapy. Cell Death Dis. 3(11):980. (IF: 9.62)（向娟娟组）
20. Wang D, Tang L, Zhang Y, Ge G, Jiang X, Mo Y, Wu P, Deng X, Li L, Zuo S, Yan Q, Zhang S, Wang F, Shi L, Li X, Xiang B, Zhou M, Liao Q, Guo C, Zeng Z, Xiong W*, Gong Z*. Regulatory pathways and drugs associated with ferroptosis in tumors. Cell Death Dis. 2022 Jun 10. (IF: 9.62)（熊炜组）
21. Junjun Li, Yongchang Zhang, Li Wang, Min Li, Jianbo Yang, Pan Chen, Jie Zhu, Xiayu Li, Zhaoyang Zeng, Guiyuan Li, Wei Xiong, James B McCarthy, Bo Xiang, Mei Yi. FOXA1 prevents nutrients deprivation induced autophagic cell death through inducing loss of imprinting of IGF2 in lung adenocarcinoma. Cell Death Dis. 2022 Aug 16;13(8):711. (IF: 9.62)（向波组）
22. Xu HJ, Yan XJ, Zhu HC, Kang YB, Luo WR, Zhao J, Zhou KF, Liu XW, Ye L, Zhou QW, Li SS, Zhao M, Wang L, Zhu B, Liu WD, Li JX, Jiang XJ, Ren CP. TBL1X and Flot2 form a positive feedback loop to promote metastasis in nasopharyngeal carcinoma. INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES. 18(3): 1134 - 1149. (IF: 9.455)（任彩萍组）
23. Liu Y, Ouyang L, Mao C, Chen Y, Li T, Liu N, Wang Z, Lai W, Zhou Y, Cao Y, Liu S, Liang Y, Wang M, Liu S, Chen L, Shi Y, Xiao D, Tao Y. PCDHB14 promotes ferroptosis and is a novel tumor suppressor in hepatocellular carcinoma. oncogene. 41(27):3570 - 3583. (IF: 9.273)（陶永光组）
24. Ouyang J, Zhong Y, Zhang Y, Yang L, Wu P, Hou X, Xiong F, Li X, Zhang S, Gong Z, He Y, Tang Y, Zhang W, Xiang B, Zhou M, Ma J, Li Y, Li G, Zeng Z, Guo C*, Xiong W*. Long non - coding RNAs are involved in alternative splicing and promote cancer progression. Br J Cancer. 2021 Nov 8. (IF: 9.075)（熊炜组）
25. Shi N, Zhou YYH, Liu YJ, Zhang R, Jiang XJ, Ren CP*, Gao X*, Luo, LL*. PD - 1/LAG - 3 bispecific antibody potentiates T cell activation and increases antitumor efficacy. Frontiers in Immunology. 13:1047610. (IF: 8.877)（任彩萍组）
26. Wen Y, Ma J*. Phase separation drives the formation of biomolecular condensates in the immune system. Frontiers in Immunology. 13:986589. (IF: 8.877)（马健组）
27. Zhao C, Xie W, Zhu HC, Zhao M, Liu WD, Wu ZP, Wang L, Zhu B, Li SS, Zhou Y, Jiang XJ, Xu Q, Ren C. LncRNAs and their RBPs: How to influence the fate of stem cells? STEM CELL RESEARCH & THERAPY. 13(1): 175. (IF: 8.387)（任彩萍组）
28. Sheng Yang, Zhen Liu, Shengda Wu, Lang Zou, Yanpei Cao, Hongjia Xu, Jingfeng Huang, Qingyan Tian, Fanggui Wu, Panpan Li, Shuping Peng, Cijun Shuai. Meiosis resumption in human primordial germ cells from induced pluripotent stem cells by in vitro activation and reconstruction of ovarian nests. STEM CELL RESEARCH & THERAPY. 13. (IF: 8.387)（彭淑平组）
29. Li SS, Zhu HC, Zhao M, Liu WD, Wang L, Zhu B, Xie W, Zhao C, Zhou Y, Ren CP. When stem cells meet COVID - 19: recent advances, challenges and future perspectives. STEM CELL RESEARCH & THERAPY 13(1): 9. (IF: 8.381) (任彩萍组)
30. Chen X, Li Y, Rubio K, Deng B, Li Y, Tang Q, Mao C, Liu S, Xiao D, Barreto G, Tao Y. Lymphoid - specific helicase in epigenetics, DNA repair and cancer. British Journal of Cancer 126(2):165 - 17. (IF: 8.329) (陶永光组)
31. Xue C, Wei J, Li M, Chen S, Zheng L, Zhan Y, Duan Y, Deng H, Xiong W, Li G, Li H*, Zhou M*. The Emerging Roles and Clinical Potential of circSMARCA5 in Cancer. Cells 11(19): 3074. (IF: 7.677) (周鸣组)
32. Shuai W, Huiting L, Jiheng L, Qianqian Z, Wei X, Juanjuan X, Li F, Ping X, Zheng L. Integrative analysis of m3C associated genes reveals METTL2A as a potential oncogene in breast Cancer. Journal of Translational Medicine 2022; 20:476 - 492. (IF: 7.547) (李征组)
33. Zeng F, He J, Jin X, Liao Q, Chen Z, Peng H, Zhou Y. FRA - 1: A key factor regulating signal transduction of tumor cells and a potential target molecule for tumor therapy. Biomed Pharmacother. 150:113037. (IF: 7.419) (周艳宏组)
34. Li W, Liang L, Liao Q, Li Y, Zhou Y. CD38: An important regulator of T cell function. Biomed Pharmacother. 153:113395. (IF: 7.419) (周艳宏组)
35. Liu Z, Zhou Y, Xia J. CircRNAs: Key molecules in the prevention and treatment of ischemic stroke. Biomed Pharmacother. 156:113845. (IF: 7.419) (周艳宏组)
36. Zheng L, Yancheng Z, Tiantian H, Shuping P, Liuyimei Y. A Codispersed Nanosystem of Silver - anchored MoS2 Enhances Antibacterial and Antitumor Properties of Selective Laser Sintered Scaffolds. INTERNATIONAL JOURNAL OF BIOPRINTING 8: 111–125. (IF: 7.393) (彭淑平组)
37. Jia W, Zhu HC, Zhao M, Zhou QW, Yin W, Liu WD, Wang L, Xiao ZF, Jiang XJ*, Dai JW*, Ren CP*. Potential mechanisms underlying the promoting effects of 3D collagen scaffold culture on stemness and drug resistance of glioma cells. BIOCHIMICA ET BIOPHYSICA ACTA - MOLECULAR BASIS OF DISEASE 1868(11): 166522. (IF: 6.919) (任彩萍组)
38. Qu H, Chen M, Ge J, Zhang X, He S, Xiong F, Yan Q, Zhang S, Gong Z, Guo C, Wang F, Zeng Z, Li X, Li G, Xiong W*, Wu X*. A fluorescence strategy for circRNA quantification in tumor cells based on T7 nuclease - assisted cycling enzymatic amplification. Anal Chim Acta. 2022 Jan 2; 1189: 339210. (IF: 6.911) (熊炜组)
39. Cijun S, Shiwei Z, Zhi D, Chongxian H, Yang S, Youwen Y, Wenjing Y, Shuping P. A bifunctional bone scaffold combines osteogenesis and antibacterial activity via in situ grown hydroxyapatite and silver nanoparticles. BIO - DESIGN AND MANUFACTURING 8: 1841 - 1851. (IF: 6.795) (彭淑平组)
40. Kuang YR, Shen W, Zhu HC, Huang HX, Zhou QW, Yin W, Zhou Y, Cao YD, Wang L, Li XW, Ren CP, Jiang XJ. The role of lncRNA just proximal to XIST (JPX) in human disease phenotypes and RNA methylation: The novel biomarker and therapeutic target potential. BIOMEDICINE & PHARMACOTHERAPY 155: 113753. (IF: 6.581) (任彩萍组)
41. Yihui W, Qin Y, Yinghong Z, Xingxing J, Jiaojiao G, Jingyu Z, Chunmei K, Xiangling F, Gang A, Lugui Q, Guancheng L, Yanjuan H, Wen Z. Intestinal Klebsiella pneumoniae Contributes to Pneumonia by Synthesizing Glutamine in Multiple Myeloma. Cancers 14(17):4188. (IF: 6.575) (周文组)
42. Zheng R, Ma J*. Immunotherapeutic implications of Toll - like receptors activation in tumor microenvironment. Pharmaceutics 14(11):2285. (IF: 6.53) (马健组)
43. Zeng F, Zhu L, Liao Q, Li X, Zhou Y. Adenosine diphosphate ribose cyclase: An important regulator of human pathological and physiological processes. J Cell Physiol 237(4):2064 - 2077. (IF: 6.513) (周艳宏组)
44. Zeng F, Zhang J, Jin X, Liao Q, Chen Z, Luo G, Zhou Y. Effect of CD38 on B - cell function and its role in the diagnosis and treatment of B - cell - related diseases. J Cell Physiol. 237(7):2796 - 2807. (IF: 6.513) (周艳宏组)
45. Cao YD, Zhu HC, Chen Q, Huang HL, Xie DC, Li XW, Jiang XJ, Ren CP, Peng JH. Integrated analysis of inflammatory response subtype - related signature to predict clinical outcomes, immune status and drug targets in lower - grade glioma. FRONTIERS IN PHARMACOLOGY 13: 914667. (IF: 6.455) (任彩萍组)
46. Zheng L, Li M, Wei J, Chen S, Xue C, Zhan Y, Duan Y, Deng H, Xiong W, Li G, Zhou M*. The emerging roles of the interaction between m6A modification and c - Myc in driving tumorigenesis and development. Journal of Cellular Physiology 237(7):2758 - 2769. (IF: 6.398) (周鸣组)
47. Li W, Li Y, Jin X, Liao Q, Chen Z, Peng H, Zhou Y. CD38: A Significant Regulator of Macrophage Function. Front Oncol. 12:775649. (IF: 6.244) (周艳宏组)
48. Jiaqi X, Xiang F, Na Y, Lujuan W, Yaohuan X, Yawen G, Juanjuan X. Exosomes from cisplatin - induced dormant cancer cells facilitate the formation of premetastatic niche in bone marrow through activating glycolysis of BMSCs. Frontiers in Oncology 2022 Dec 9. (IF: 6.244) (向娟娟组)
49. Jun Z, Guowen Q, Fang D, Jun Z, Zhikui Z, Shuping P, Cijun S. Dilemma and breakthrough of biodegradable poly - l - lactic acid in bone tissue repair. JOURNAL OF MATERIALS RESEARCH AND TECHNOLOGY - JMR&T 17: 2369 - 2387. (IF: 6.213) (彭淑平组)
50. Shen WY, Zhou QW, Peng CX, Li JH, Yuan QZ, Zhu HC, Zhao M, Jiang XJ, Liu WD, Ren CP. FBXW7 and the Hallmarks of Cancer: Underlying Mechanisms and Prospective Strategies. FRONTIERS IN ONCOLOGY 12: 880077. (IF: 6.122) (任彩萍组)
51. Ruixue Y, Mei Y*, Bo X*. Novel Insights on Lipid Metabolism Alterations in Drug Resistance in Cancer. Front Cell Dev Biol. 2022 May 13;10:875318. (IF: 6.081) (向波组)
52. Zhao M, Wang Y, Tan F, Liu L, Hou X, Fan C, Tang L, Mo Y, Wang Y, Yan Q, Gong Z, Li Z, Liao Q, Guo C, Huang H, Zeng X, Li G, Zeng Z, Xiong W*, Wang F*. Circular RNA circCCNB1 inhibits the migration and invasion of nasopharyngeal carcinoma through binding and stabilizing TJP1 mRNA. Sci China Life Sci. 2022 Apr 21. (IF: 6.038) (熊炜组)
53. Liang L, Li W, Li X, Jin X, Liao Q, Li Y, Zhou Y. 'Reverse Warburg effect' of cancer associated fibroblasts (Review). Int J Oncol. 60(6):67. (IF: 5.884) (周艳宏组)
54. Cijun S, Shiwei Z, Zhi D, Chongxian H, Yang S, Youwen Y, Wenjing Y, Shuping P, Shuping P*. Stress - Induced Dual - Phase Structure to Accelerate Degradation of the Fe Implant. ACS BIOMATERIALS SCIENCE & ENGINEERING 8: 1841 - 1851. (IF: 5.77) (彭淑平组)
55. Li L, Zhou J, Dong X, Liao Q, Zhou D, Zhou Y. Dendritic cell vaccines for glioblastoma fail to complete clinical translation: Bottlenecks and potential countermeasures. Int Immunopharmacol. 109:108929. (IF: 5.714) (周艳宏组)
56. Zhang Y, Li M, Guo Y, Liu S, Tao Y. The Organelle - Specific Regulations and Epigenetic Regulators in Ferroptosis. Front Pharmacol. 13:905501. (IF: 5.615) (陶永光组)
57. Li S, Mo YQ, Gao CD, Shuai CJ, Peng SP*. A dual redox system for enhancing the biodegradability of Fe - C - Cu composite scaffold. Colloids and Surfaces B - Biointerfaces. 213. (IF: 5.596)（彭淑平组）
58. Cao YD, Zhu HC, Liu WD, Wang L, Yin W, Tan J, Zhou QW, Xin ZQ, Huang HL, Xie DC, Zhao M, Jiang X, Peng JH, Ren CP*. Multi - Omics Analysis Based on Genomic Instability for Prognostic Prediction in Lower - Grade Glioma. Frontiers in Genetics. 12: 758596. (IF: 4.933)（任彩萍组）
59. Qi FW, Wang ZH, Shuai Y, Peng SP, Shuai CJ*. Sr2+ Sustained Release System Augments Bioactivity of Polymer Scaffold. ACS Applied Polymer Materials. 4: 2691 - 2702. (IF: 4.855)（彭淑平组）
60. Liu ZH, Zhang SW, Li H, Guo JJ, Wu D, Zhou W, Xie L*. Cellular Interaction Analysis Characterizing Immunosuppressive Microenvironment Functions in MM Tumorigenesis From Precursor Stages. Frontiers in Genetics. 13:844604. (IF: 4.772)（周文组）
61. Luo Y, Wang X, Niu W, Zhou Y, Li M, Ma J, Yang J, Fan S, Zeng Z, Xiong W, Li X, Li G, Xiao J, Zhou M*. BRD7 Stabilizes P53 via Dephosphorylation of MDM2 to Inhibit Tumor Growth in Breast Cancer Harboring Wild - type P53. Journal of Cancer. 13(5):1436 - 1448. (IF: 4.505)（周鸣组）
62. Wu P, Liu Y, Zhou R, Liu L, Zeng H, Xiong F, Zhang S, Gong Z, Zhang W, Guo C, Wang F, Zhou M, Zu X, Zeng Z, Li Y, Li G, Huang H*, Xiong W*. Extrachromosomal Circular DNA: A New Target in Cancer. Front Oncol. 2022 Apr 14; 12: 814504. (IF: 4.137)（熊炜组）
63. Fan C, Xiong F, Tang Y, Li P, Zhu K, Mo Y, Wang Y, Zhang S, Gong Z, Liao Q, Li G, Zeng Z, Guo C, Xiong W*, Huang H*. Construction of a lncRNA-mRNA Co-Expression Network for Nasopharyngeal Carcinoma. Front Oncol. 2022 Jul 7; 12:809760. (IF: 4.137)（熊炜组）
64. Liu FX, Li GC, Li J, Gui R, Luo YW*, Zhou M*. A novel mutation eliminates GATA - 1 and RUNX1-mediated promoter activity in galactosyltransferase gene. Transfusion Medicine and Hemotherapy. (IF: 3.617)（周鸣组）
65. Kong LL, Xu JQ, Yu LJ, Liu S, Liu ZJ, Xiang JJ*. Construction of PARPi Resistance - related Competing Endogenous RNA Network. Current genomics. 2022, 23, 262 - 274. (IF: 3.528)（向娟娟组）
66. Shi N, Wang ZH, Zhu HC, Liu WD, Zhao M, Jiang XJ, Zhao J, Ren CP, Zhang Y, Luo LL*. Research progress on drugs targeting the TGF - beta signaling pathway in fibrotic diseases. Immunologic Research. 70(3): 276 - 288. (IF: 3.523)（任彩萍组）
67. Liu ZH, Zhang SW, Ouyang J, Wu D, Chen LM, Zhou W, Xie L*. Single-Cell RNA-seq Analysis Reveals Dysregulated Cell-Cell Interactions in a Tumor Microenvironment Related to HCC Development. Disease Markers. 2022:4971621. (IF: 3.464)（周文组）
68. Liu C, Peng Q, Wei L, Li Z, Zhang X, Wu Y, Wang J, Zheng X, Wen Y, Zheng R, Yan Q, Ye Q*, Ma J*. Deficiency of Lactoferrin aggravates lipopolysaccharide - induced acute inflammation via recruitment macrophage in mice. Biometals. 2022 Jun 1;1 - 14. (IF: 3.38)（马健组）
69. Yang J, Peng SP, Zhang KQ*. ARL4C depletion suppresses the resistance of ovarian cancer to carboplatin by disrupting cholesterol transport and autophagy via notch - RBP - Jκ - H3K4Me3 - OSBPL5. Human & Experimental Toxicology. 41: 1–16. (IF: 3.045)（彭淑平组）
70. Zou Z, He TT, Liu Y, Zheng LL, Zhong YC, Mo YQ, Peng SP, Shuai CJ*. Emerging role of m6A modification in osteogenesis of stem cells. Journal of Bone and Mineral Metabolism. 40:177–188. (IF: 2.922)（彭淑平组）
